DE Gaudio M, Chiappini E, Galli L, DE Martino M
Department of Pediatrics, University of Florence, Florence, Italy.
J Chemother. 2010 Aug;22(4):226-37. doi: 10.1179/joc.2010.22.4.226.
Bacterial meningitis is an infectious disease emergency that can cause substantial morbidity and mortality. We compared the most recent international guidelines and recommendations on bacterial meningitis management in infants and children in developed countries, in terms of initial management approach, empirical antimicrobial therapy, timing, dosages, and duration of antimicrobial therapy, and possible adjunctive treatment with dexamethasone. Secondly, epidemiological data on bacterial resistance in several european countries were analyzed and discussed in relation to the therapies currently recommended for bacterial meningitis. The comparative analysis of the selected guidelines highlighted significant differences in the therapeutic management of bacterial meningitis. Differences among guidelines have important consequences for daily practice. An agreed protocol for early, evidence-based, and effective therapeutic management of bacterial meningitis is essential for the best outcome. further studies and expert consensus are required to establish the best management of bacterial meningitis in the european setting based on the most recent epidemiological data on resistance rates.
细菌性脑膜炎是一种可导致严重发病和死亡的感染性疾病急症。我们比较了发达国家关于婴幼儿细菌性脑膜炎管理的最新国际指南和建议,内容涉及初始管理方法、经验性抗菌治疗、抗菌治疗的时机、剂量和疗程,以及使用地塞米松进行辅助治疗的可能性。其次,分析并讨论了几个欧洲国家的细菌耐药性流行病学数据,并将其与目前推荐的细菌性脑膜炎治疗方法相关联。对所选指南的比较分析突显了细菌性脑膜炎治疗管理方面的显著差异。指南之间的差异对日常实践具有重要影响。制定一项基于证据的早期有效治疗细菌性脑膜炎的商定方案对于取得最佳治疗效果至关重要。需要进一步开展研究并达成专家共识,以便根据最新的耐药率流行病学数据,确定欧洲环境下细菌性脑膜炎的最佳管理方法。